^○Hiroki Suga¹, Takahiro Iizuka¹, Juntaro Kaneko¹, Atsuko Yanagida¹, Atsushi Kaneko^1,2, Eiji Kitamura¹, Naomi Kanazawa¹, Tsugio Akutsu¹, Kazutoshi Nishiyama¹ (1.Department of Neurology, Kitasato University School of Medicine, Japan, 2.Department of Neurology, Kitasato University Medical Center)

^○Hiroshi Kuroda^1,2, Kimihiko Kaneko¹, Takaaki Nakamura¹, Yoshiki Takai¹, Shuhei Nishiyama¹, Tatsuro Misu¹, Kazuo Fujihara^1,3,4, Masashi Aoki¹ (1.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 2.Department of Neurology, South Miyagi Medical Center, Japan, 3.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, 4.Department of Multiple Sclerosis Therapeutics, Southern TOHOKU Research Institute for Neuroscience)

^○Shinsei Hirohata^1,2, Hirotoshi Kikuchi², Tamiko Yanagida² (1.Nobuhira Hospital & Institute of Biomechanics, Japan, 2.Teikyo University School of medicine, Japan)

^○Toshi Sai¹, Daiki Takewaki¹, Chihiro Fujii¹, Shinji Ashida¹, Rei Yasuda¹, Yukiko Tsuji¹, Jun Fujinami¹, Atsushi Yamamoto², Takuma Katou², Keisuke Imai², Toshiki Mizuno¹ (1.Department of Neurology Treatment, Kyoto prefecture university of medicine, Japan, 2.Department of Neurology and Stroke Treatment, Acute Stroke Center of Kyoto First Red Cross Hospital)

^○Miwako Fujisawa, Yukio Takeshita, Susumu Fujikawa, Fumitaka Shimizu, Toshihiko Maeda, Yasuteru Sano, Michiaki Koga, Takashi Kanda (Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan)

^○Akihiro Mukaino^1,2, Shunya Nakane^1,2, Osamu Higuchi³, Yasuhiro Maeda³, Makoto Yamakawa², Kotaro Takamatsu², Hidenori Matsuo³ (1.Department of Molecular Neurology and Therapeutics, Kumamoto University Hospital, Japan, 2.Department of Neurology, Kumamoto University, Japan, 3.Department of Clinical Research and Neurology, Nagasaki Kawatana Medical Center, Japan)

^○Ulfa C. Indiasari, Katsuhisa Masaki, Ryo Yamasaki, Hiroo Yamaguchi, Yuko Nakamuta, Kyoko Iinuma, Jun-ichi Kira (Department of Neurology, Kyushu University, Japan)

^○Kazuo Fujihara¹, Benjamin Greenberg², Jerome De Seze³, Edward Fox⁴, Albert Saiz⁵, Takashi Yamamura⁶, Carole Marcillat⁷, Xiujing Kou⁷, Kristina Weber⁷, Brian G. Weinshenker⁸ (1.Multiple Sclerosis and Neuromyelitis Optica Center, Southern Tohoku Research Institute for Neuroscience, Japan, 2.University of Texas Southwestern Medical Center, 3.Department of Neurology, Hôpital de Hautepierre INSERM, 4.Central Texas Neurology Consultants, 5.Service of Neurology, University of Barcelona, 6.National Institute of Neuroscience, National Center of Neurology and Psychiatry, 7.F. Hoffmann-La Roche Ltd, 8.Department of Neurology, Mayo Clinic)

^○Ryuji Kubota¹, Masakazu Tanaka¹, Eiji Matsuura², Hiroshi Takashima² (1.Joint Research Center for Human Retrovirus Infection, Kagoshima University, Japan, 2.Department of Neurology and Geriatrics, Kagoshima University)

^○Hiroo Yamaguchi¹, Tatsunori Tanaka¹, Dai Matsuse¹, Yuji Nishimura¹, Katsuhisa Masaki¹, Toru Saiga¹, Mitsuru Watanabe¹, Ryo Yamasaki¹, Kenji Tanaka², Jun-ichi Kira¹ (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Department of Neuropsychiatry, School of Medicine, Keio University)